Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 22, 2026.

Lymphatic Migration of Immune Cells

Henry R. Hampton, Tatyana Chtanova

Frontiers in Immunology · 2019 · Review · CC BY

doi:10.3389/fimmu.2019.01168 (opens in a new tab)

Abstract

Lymphatic vessels collect interstitial fluid that has extravasated from blood vessels and return it to the circulatory system. Another important function of the lymphatic network is to facilitate immune cell migration and antigen transport from the periphery to draining lymph nodes. This migration plays a crucial role in immune surveillance, initiation of immune responses and tolerance. Here we discuss the significance and mechanisms of lymphatic migration of innate and adaptive immune cells in homeostasis, inflammation and cancer.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 22, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

The lymphatic system transports fluids from the periphery back into the circulatory system using a series of open-ended capillaries known as lymphatic vessels. This network can be exploited by pathogens to facilitate rapid spread throughout the host. To prevent pathogen dissemination and enable a fast targeted immune response, the lymphatic system possesses filter-like structures termed lymph nodes (LNs), where innate immune cells, such as macrophages, neutrophils and dendritic cells (DCs) trap and kill pathogens and activate the adaptive immune response.

There are two routes by which immune cells can enter LNs: leukocytes can arrive from the bloodstream by crossing high endothelial venules (HEVs). Alternatively, tissue-resident immune cells can enter afferent lymphatic vessels and migrate to draining LNs (dLNs). Cells of the innate immune system including DCs, neutrophils, monocytes as well as adaptive immune leukocytes, such as T and B cells use lymphatic vessels to migrate from tissues into LNs. Lymphocytes exit LNs via efferent lymphatic vessels, and eventually return to the circulatory system by the thoracic duct, however, in this review we will focus on the mechanisms and consequences of immune cell migration via the afferent lymphatic system.

In vitro and ex vivo models including adhesion and transmigration assays and analysis of immune cell migration in explanted skin provided important mechanistic insight into leukocyte entry and migration within lymphatic vessels, while in vivo approaches allowed to examine this complex biological process in situ (Table 1). Historically, in vivo analysis of immune cell migration in afferent lymphatics involved direct transfer of immune cells into the skin, lymphatic cannulation, as well application of fluorescent sensitizers to the skin to label cells and induce inflammation. More recently photoconvertible transgenic mice have been utilized to track immune cell migration from the skin and tumors, while intravital imaging approaches, such as in vivo two-photon microscopy enabled direct visualization of immune cell migration in lymphatic vessels.

Dendritic Cells

There are two distinct DC populations: plasmacytoid, which produce high amounts of type 1 interferon, and conventional DCs (cDCs). Upon sensing inflammatory stimuli, cDCs enter lymphatic vessels and migrate to LNs. They carry antigens and pathogens including viruses, spores and bacteria from the site of infection to LNs, while DC-mediated transport of innocuous antigens regulates tolerance. In dLNs DCs present antigen to CD4+ T cells, or cross-present to CD8+ T cells, thereby regulating adaptive immune responses. DC migration from the periphery has been discussed extensively in several recent reviews. Here we provide a brief overview of the mechanisms of DC migration via lymphatic vessels (Figure 1).

The most important regulator of DC migration is the chemokine receptor CCR7. Consistent with this, CCR7-deficient DCs show a 90 percent reduction in migration from the periphery in response to inflammatory stimuli. An elegant intravital microscopy study demonstrated that CCR7 is required for the LPS-induced directed migration of DCs toward lymphatic vessels and subsequent transmigration. DCs also use CCR7 for trafficking to dLNs from the lamina propria, lung, and skin under homeostatic conditions. Interestingly, CCR7-dependent DC migration decreases lymphatic permeability, indicating bi-directional communication between the lymphatic network and immune cells.

Lymphatic vessels express CCR7 ligand, CCL21, which is required for DC trafficking from skin to LNs under homeostatic and inflammatory conditions. Imaging studies have provided important insight into the role of CCL21 in DC migration. Firstly, the size of the CCL21 gradient, and distribution of lymphatic vessels, indicates that most skin DCs are able to sense CCL21 gradients. Secondly, DCs enter lymphatic vessels at sites of high CCL21 expression, suggesting that CCL21 directly regulates entry into lymphatics. Finally, intravital microscopy has revealed that CCL21 also enhances DC migration within lymphatic vessels. Collectively, these observations suggest that CCL21 regulates multiple steps in the lymphatic migration of DCs. In contrast, the other CCR7 ligand, CCL19, appears to be dispensable for DC lymphatic trafficking.

Inflammatory mediators regulate DC lymphatic migration. The cytokines Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α) promote inflammation-induced DC migration to LNs. Furthermore, the lipid prostaglandin E2 increased CCR7 expression on DCs, augmenting migration towards CCL19 and CCL21 in vitro. Additional regulators of CCR7-mediated migration include the cell surface molecules CD37, CD38, and CD47 which enhance DC movement toward CCR7 ligands and migration to dLNs. In contrast, immunosuppressive molecules including IL-10, TGF-β and the anti-inflammatory lipid Resolvin E1 can inhibit DC trafficking.

In addition to CCR7, a number of other chemokine receptor/ligand pairs have been implicated in lymphatic DC migration. CXCR4/CXCL12 and CX3CR1/CX3CL1 enhance DC trafficking from inflamed skin. The role of CCR8 is less clear with CCR8-deficient mice displaying reduced lymphatic migration of DCs following an injection of latex beads, but enhanced migration of DCs following FITC painting, suggesting that CCR8 plays a limited, or stimulus-specific, role in this process.

Intravital imaging and FITC-painting experiments have demonstrated that integrins, and integrin signaling are required for inflammation-induced DC migration to dLNs. However, DCs from mice lacking all integrins were able to migrate to LNs when injected into resting skin, indicating that integrins are important for DC migration in response to inflammation but dispensable for steady state DC egress. Accordingly, inflammation increases the expression of integrin ligands on lymphatic endothelial cells (LECs). DC-expressed L1 cell adhesion molecule guides transendothelial migration of DCs thereby promoting trafficking to dLNs. A recent study demonstrated that interactions between LEC-expressed LYVE-1 and hyaluronan on the DC plasma membrane mediated DC adhesion and transmigration across LECs and subsequent migration to dLNs.

Sphingosine-1-phosphate (S1P), a lipid mediator of leukocyte egress from lymphoid organs, has been implicated in DC trafficking from the skin and lung. However, in mice that lack S1P in lymphatic fluid, but not blood, the migration of adoptively transferred DCs to dLNs was comparable to that seen in wild-type mice. These results, and the fact that there are five S1P receptors, suggest that further experiments are required to uncover the precise role of S1P signaling in DC migration.

In contrast to cDCs, the lymphatic migration of pDCs is poorly understood. While one study reported that adoptively transferred pDCs migrated to dLNs from ovine skin, another showed that pDCs were not detected in the lymph of rats. However, pDCs transported harmless inhaled antigen from murine lungs to the mediastinal LN where they suppressed T cell activation, suggesting that pDC migration may play a role in preventing inflammation.

Neutrophils

Neutrophils are the first immune cells recruited to sites of inflammation, where they kill pathogens and release mediators that recruit other leukocytes. Until recently neutrophils were thought to die at inflammatory foci. However, several groups, including ours, have shown that neutrophils can enter tissue lymphatic vessels and migrate to dLNs from the site of inflammation.

Intravital imaging of inflamed mouse skin has enabled direct visualization of neutrophil migration within lymphatic vasculature (Figure 2A). However, in comparison to DCs, the significance and extent of neutrophil lymphatic migration are incompletely understood. Cannulation experiments have demonstrated that inflammation leads to a dramatic increase in neutrophils in ovine afferent lymph. Furthermore, neutrophils can transport antigens and microorganisms (Figure 2B) from the site of infection to LNs. Accordingly, inhibiting neutrophil lymphatic migration reduced early lymphocyte proliferation. Notably, a recent study did not detect substantial lymphatic migration of neutrophils in response to Staphylococcus aureus (S. aureus). This likely highlights the fact that most neutrophils arrive in dLNs from the circulation via HEVs in response to bacteria already in dLNs, while a smaller population of neutrophils migrates directly from the site of inflammation to dLNs via afferent lymphatics. However, since neutrophils are the first innate immune cell subset to arrive in the LN from inflamed tissues, and often carry microbes, neutrophil lymphatic migration can exert considerable influence on the subsequent adaptive immune response.

Lymphatic migration of neutrophils could potentially be exploited by pathogens to enhance dissemination, since some microorganisms including the bacterium S. aureus can survive inside neutrophils. Consistent with this, injection of Leishmania major-containing neutrophils was sufficient to establish infection in mice, while depleting neutrophils reduced Leishmania burden when the pathogen was injected into the skin. Neutrophils also transported live Mycobacterium bovis bacille Calmette-Guérin from the skin to dLNs. In Toxoplasma gondii infection neutrophils removed the macrophages that line the subscapular sinus of the LN, however, it is not clear whether this favors pathogen control or spread.

CCR7 appears to be less important for neutrophil lymphatic migration than for that of DCs. Although it was required for neutrophil entry into lymphatic vessels in response to TNF-α and Complete Freund's Adjuvant (CFA), and for CFA-driven migration from skin to LNs, neutrophil migration from the skin to dLNs in response to S. aureus was CCR7-independent. This suggests that the requirements for neutrophil trafficking vary depending on the stimulus and additional molecules may play key roles in guiding this migration.

The chemokine receptor CXCR4 regulates neutrophil migration from the bone marrow into the circulation and may also play a role in their lymphatic migration. Inhibiting CXCR4 decreased neutrophil trafficking in response to immune complexes and S. aureus. However, CXCR4 was not required for neutrophil entry into lymphatic vessels in response to CFA, as revealed by confocal imaging, again highlighting differences in neutrophil trafficking in response to distinct stimuli.

The cell surface receptor CD11b, which is involved in neutrophil recruitment from the vasculature into tissues, is emerging as a major regulator of neutrophil migration via lymphatics since neutrophil migration from inflammatory foci to LNs is substantially reduced when CD11b is inhibited. Intravital imaging demonstrated that blocking CD11b or its ligand ICAM-1 impaired neutrophil intraluminal crawling within lymphatic vasculature following CFA injection by reducing neutrophil speed and directionality. Likewise, inhibiting CD11b and ICAM-1 reduced neutrophil entry into lymphatic vessels and diminished egress from the skin in response to Mycobacterium bovis. Lymphocyte Function-associated Antigen (LFA-1), which binds to ICAMs and is involved in neutrophil entry into tissues from the circulation, was required for neutrophil migration via afferent lymphatics in response to immune complexes but not S. aureus.

Inflammatory cytokines may enhance neutrophil entry into lymphatics. TNF-α promoted neutrophil entry and crawling within lymphatic vessels in mouse cremaster muscle. However, since inflammatory cytokines also control neutrophil recruitment to sites of inflammation and lifespan, identifying a distinct role for these molecules in neutrophil lymphatic migration requires further investigation.

Monocytes and Macrophages

Monocytes are circulating leukocytes that phagocytose and kill bacteria and fungi and regulate the activity of other immune cells via cytokine release. They can also differentiate into DC and macrophage subsets. Several studies have demonstrated that monocytes egress tissues via afferent lymphatic vessels and transport antigen to dLNs. Once there, monocytes may present and cross-present antigens since a subcutaneous injection of antigen-pulsed monocytes induced the proliferation of antigen-specific CD4+ and CD8+ T cells. The molecular mechanisms controlling monocyte migration via lymphatic vessels are yet to be identified. However, CCR7 may be important, since CCR7-deficient LPS-primed monocytes failed to migrate from the footpad to the popliteal LN. Accumulating evidence suggests that macrophages can also migrate from inflammatory lesions to dLNs and that α1β1 integrin may limit macrophage egress via afferent lymphatics.

T Cells

T cells possess a rearranged T cell receptor which includes either αβ or γδ polypeptides. While αβ T cells are more abundant, γδ T cells are enriched in epithelial and mucosal tissues where they act as the first line of defense against pathogens. One of the main functions of CD8+ T cells is to kill infected cells, while CD4+ helper T cells secrete cytokines and regulate the function of other immune subsets. Photoconversion experiments, along with lymphatic cannulation, have demonstrated that effector, rather than naïve, T cells comprise the majority of lymph migrating T cells under homeostatic and inflammatory conditions. This migration plays an important role in immune surveillance and in resolution of inflammation.

Like DCs, T cells use CCR7 to migrate to LNs under homeostatic and inflammatory conditions. Following antigen challenge, T cells overexpressing CCR7 were preferentially lost from the lung and accumulated in the mediastinal LNs, while CCR7-deficient T cells failed to migrate from the footpad to the popliteal LN. However, the need for CCR7 in T cell migration might be context dependent, as T cells used CCR7 for trafficking from acute, but not chronically, inflamed skin. Tumor-infiltrating T cells could also emigrate to dLNs independently of CCR7.

The lipid S1P, which promotes αβ T cell exit from LNs, can also mediate their migration via afferent lymphatics. Consequently, antagonizing S1P receptors led to T cell accumulation near skin lymphatic vessels and reduced migration to dLNs. LEC-expressed macrophage mannose receptor (MR) and the cell surface molecule CD44, which interacts with MR, promoted T cell lymphatic migration by increasing T cell adhesion to lymphatic vessels. Another LEC-expressed protein, CLEVER-1, was also demonstrated to be important for T cell migration via afferent lymphatics. Additionally, intravital imaging has shown that LFA-1 and its ligand ICAM-1, increased T cell velocity within afferent lymphatic vessels thereby promoting T cell migration to dLNs.

T cell egress from tissues to dLNs can either promote inflammatory responses or suppress them. For example, lymphatic migration of Regulatory T (Treg) cells may suppress allograft rejection. Likewise, CCR7-deficient Treg cells failed to migrate to the draining LN and accumulated in the skin, reducing skin inflammation during a delayed-type hypersensitivity reaction. Conversely, overexpression of CCR7 on antigen-specific Th1-cells enhanced their egress to dLNs and led to faster resolution of the inflammatory response in the skin.

Like αβ T cells, γδ T cells can migrate from the skin and tumors via lymphatic vessels to dLNs and comprise a large proportion of the cells in bovine lymph. Photoconversion experiments have demonstrated that murine γδ T cells can migrate from the skin to dLNs in the absence of CCR7. Similarly, bovine γδ T cells can egress tissues independently of this receptor. The consequences of γδ T cell lymphatic migration are poorly understood, though it may enhance CD8+ T cell proliferation.

B Cells

Cannulation experiments in sheep and photoconversion experiments in mice, suggest that B cells use afferent lymphatic vessels to migrate from tissues to dLNs. The mechanisms of this migration are not yet known, however, at least in chronic inflammation, B cell egress may be independent of S1P and requires CCR7. Similarly to T cells, blocking CLEVER-1 reduced B cell migration to dLNs.

Lymphatic Migration of Immune Cells in Disease

The importance of immune cell migration via lymphatics in host defense is illustrated by the observations that mice lacking CCR7 are susceptible to microbial and viral infections. On the other hand, lymphatic migration of immune cells may also augment autoimmunity since preventing immune cell trafficking from the meninges to the cervical LNs reduced the severity of EAE. Furthermore, higher densities of lymphatic vessels in transplanted corneas and kidneys were associated with rejection, while preventing DC migration to the dLN by blocking Vascular Endothelial Growth Factor C (VEGF-C) improved corneal transplantation outcomes. Interestingly, in mice, obesity was associated with decreased lymphatic function and reduced immune cell migration to dLNs, suggesting that obesity may be linked to decreased immunity. CCR7 as well as its two ligands, CCL19 and CCL21, have been identified in mouse and human atherosclerotic lesions, consistent with accumulating evidence of a role for immune cell lymphatic migration in heart disease.

Lymphatic vasculature also plays a crucial role in tumor immunity by enabling transport of antigens from tumors to dLNs and egress of immune cells. Lymphatic vessels can also serve as conduits for tumor cell spread. Their dual role in cancer is highlighted by the findings that many tumors overexpress VEGF-C, which promotes the growth and survival of LECs leading to increased LN metastasis. Furthermore, a recent study demonstrated that IFNγ-induced PD-L1 expression by LECs may dampen anti-tumor immunity by limiting cytotoxic CD8+ T cell accumulation in melanoma. On the other hand, overexpression of VEGF-C in a mouse melanoma model increased DC migration to dLNs. Consistent with an increase in lymphatic migration in cancer, enhanced trafficking of adoptively transferred B and T lymphocytes from footpads to dLNs was observed in melanoma-bearing mice.

Similarly to DC migration from the periphery, the DC-dependent transfer of antigen from B16F10 melanoma to the dLN required CCR7. This correlated with an increase in CD8+ T cell priming and a reduction in tumor growth. Overexpression of TGF-β1 in a model of squamous cell carcinoma reduced DC trafficking to dLNs, which led to an increase in LN metastasis. However, since CCR7 and the TGF-β1 receptor are not restricted to DCs, other immune cells may also contribute to these effects on tumor growth and metastasis. In contrast to DCs, photoconversion experiments demonstrated that tumor-infiltrating T cells do not require CCR7 to migrate to dLNs via afferent lymphatics.

Concluding Remarks

Lymphatic migration of immune cells presents opportunities for control of immune responses in infection and homeostasis. However, with the exception of DCs and T cells, the mechanisms controlling lymphatic migration of immune cells remain poorly understood. New tools, such as photoconversion and intravital imaging are poised to provide novel insight into the migration of previously overlooked immune subsets. A better understanding of the distinct mechanisms guiding lymphatic migration of specific immune subsets may suggest new approaches for treatment of cancer, autoimmunity and excessive inflammation.

Author Contributions

All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 134

  1. 1.

    Alitalo K. The lymphatic vasculature in disease. Nat Med. (2011 ) 17:1371–80.

    Not in our library10.1038/nm.2545 (opens in a new tab)

  2. 2.

    Cueni LN Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol. (2006 ) 126:2167–77.

    Not in our library10.1038/sj.jid.5700464 (opens in a new tab)

  3. 3.

    Kastenmüller W Torabi-Parizi P Subramanian N Lämmermann T Germain RN. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell. (2012 ) 150:1235–48.

    Not in our library10.1016/j.cell.2012.07.021 (opens in a new tab)

  4. 4.

    Von Andrian UH Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol. (2003 ) 3:867–78.

    Not in our library10.1038/nri1222 (opens in a new tab)

  5. 5.

    Miyasaka M Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol. (2004 ) 4:360–70.

    Not in our library10.1038/nri1354 (opens in a new tab)

  6. 6.
    Microbe-dependent lymphatic migration of neutrophils modulates lymphocyte proliferation in lymph nodes · 2015
    No notice
  7. 7.

    Bonneau M Epardaud M Payot F Niborski V Thoulouze M-I Bernex F. Migratory monocytes and granulocytes are major lymphatic carriers of Salmonella from tissue to draining lymph node. J Leukoc Biol. (2006 ) 79:268–76.

    Not in our library10.1189/jlb.0605288 (opens in a new tab)

  8. 8.

    Neeland MR Elhay MJ Nathanielsz J Meeusen ENT de Veer MJ. Incorporation of CpG into a liposomal vaccine formulation increases the maturation of antigen-loaded dendritic cells and monocytes to improve local and systemic immunity. J Immunol. (2014 ) 192:3666–75.

    Not in our library10.4049/jimmunol.1303014 (opens in a new tab)

  9. 9.

    Torcellan T Hampton HR Bailey J Tomura M Brink R Chtanova T. In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors. Proc Natl Acad Sci USA. (2017 ) 114:5677–82.

    Not in our library10.1073/pnas.1618446114 (opens in a new tab)

  10. 10.

    Förster R Schubel A Breitfeld D Kremmer E Renner-Müller I Wolf E. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. (1999 ) 99:23–33.

    Not in our library10.1016/s0092-8674(00)80059-8 (opens in a new tab)

  11. 11.

    Debes GF Arnold CN Young AJ Krautwald S Lipp M Hay JB. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol. (2005 ) 6:889–94.

    Not in our library10.1038/ni1238 (opens in a new tab)

  12. 12.

    Haig DM Hopkins J Miller HR. Local immune responses in afferent and efferent lymph. Immunology. (1999 ) 96:155–63.

    Not in our library10.1046/j.1365-2567.1999.00681.x (opens in a new tab)

  13. 13.

    Johnson LA Banerji S Lawrance W Gileadi U Prota G Holder KA. Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1. Nat Immunol. (2017 ) 18:762–70.

    Not in our library10.1038/ni.3750 (opens in a new tab)

  14. 14.

    Johnson LA Clasper S Holt AP Lalor PF Baban D Jackson DG. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med. (2006 ) 203:2763–77.

    Not in our library10.1084/jem.20051759 (opens in a new tab)

  15. 15.

    Van VQ Lesage S Bouguermouh S Gautier P Rubio M Levesque M. Expression of the self-marker CD47 on dendritic cells governs their trafficking to secondary lymphoid organs. EMBO J. (2006 ) 25:5560–8.

    Not in our library10.1038/sj.emboj.7601415 (opens in a new tab)

  16. 16.

    Teijeira A Hunter MC Russo E Proulx ST Frei T Debes GF. T cell migration from inflamed skin to draining lymph nodes requires intralymphatic crawling supported by ICAM-1/LFA-1 interactions. Cell Rep. (2017 ) 18:857–65.

    Not in our library10.1016/j.celrep.2016.12.078 (opens in a new tab)

  17. 17.

    Maddaluno L Verbrugge SE Martinoli C Matteoli G Chiavelli A Zeng Y. The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells. J Exp Med. (2009 ) 206:623–35.

    Not in our library10.1084/jem.20081211 (opens in a new tab)

  18. 18.
    T Cell Trafficking through Lymphatic Vessels · 2016
    No notice
  19. 19.

    Bromley SK Yan S Tomura M Kanagawa O Luster AD. Recirculating memory T cells are a unique subset of CD4+ T cells with a distinct phenotype and migratory pattern. J Immunol. (2013 ) 190:970–6.

    Not in our library10.4049/jimmunol.1202805 (opens in a new tab)

  20. 20.

    Tomura M Yoshida N Tanaka J Karasawa S Miwa Y Miyawaki A. Monitoring cellular movement in vivo with photoconvertible fluorescence protein “Kaede” transgenic mice. Proc Natl Acad Sci USA. (2008 ) 105:10871–6.

    Not in our library10.1073/pnas.0802278105 (opens in a new tab)

  21. 21.

    Tomura M Hata A Matsuoka S Shand FHW Nakanishi Y Ikebuchi R. Tracking and quantification of dendritic cell migration and antigen trafficking between the skin and lymph nodes. Sci Rep. (2015 ) 4:6030.

    Not in our library10.1038/srep06030 (opens in a new tab)

  22. 22.

    Tomura M Honda T Tanizaki H Otsuka A Egawa G Tokura Y. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest. (2010 ) 120:883–93.

    Not in our library10.1172/jci40926 (opens in a new tab)

  23. 23.

    Nakamizo S Egawa G Tomura M Sakai S Tsuchiya S Kitoh A. Dermal Vγ4 + γδ T cells possess a migratory potency to the draining lymph nodes and modulate CD8 + T-cell activity through TNF-α production. J Invest Dermatol. (2015 ) 135:1007–15.

    Not in our library10.1038/jid.2014.516 (opens in a new tab)

  24. 24.

    Roediger B Ng LG Smith AL St. Groth BF Weninger W Visualizing dendritic cell migration within the skin. Histochem Cell Biol. (2008 ) 130:1131–46.

    Not in our library10.1007/s00418-008-0531-7 (opens in a new tab)

  25. 25.

    Tal O Lim HY Gurevich I Milo I Shipony Z Ng LG. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J Exp Med. (2011 ) 208:2141–53.

    Not in our library10.1084/jem.20102392 (opens in a new tab)

  26. 26.

    Alvarez D Vollmann EH von Andrian UH. Mechanisms and consequences of dendritic cell migration. Immunity. (2008 ) 29:325–42.

    Not in our library10.1016/j.immuni.2008.08.006 (opens in a new tab)

  27. 27.

    Worbs T Hammerschmidt SI Förster R. Dendritic cell migration in health and disease. Nat Rev Immunol. (2017 ) 17:30–48.

    Not in our library10.1038/nri.2016.116 (opens in a new tab)

  28. 28.

    Ho AWS Prabhu N Betts RJ Ge MQ Dai X Hutchinson PE. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells. J Immunol. (2011 ) 187:6011–21.

    Not in our library10.4049/jimmunol.1100987 (opens in a new tab)

  29. 29.

    Lukens MV Kruijsen D Coenjaerts FEJ Kimpen JLL Bleek GM van. Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node. J Virol. (2009 ) 83:7235–43.

    Not in our library10.1128/jvi.00452-09 (opens in a new tab)

  30. 30.

    Cleret A Quesnel-Hellmann A Vallon-Eberhard A Verrier B Jung S Vidal D. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J Immunol. (2007 ) 178:7994–8001.

    Not in our library10.4049/jimmunol.178.12.7994 (opens in a new tab)

  31. 31.

    Bravo-Blas A Utriainen L Clay SL Kästele V Cerovic V Cunningham AF. Salmonella enterica serovar typhimurium travels to mesenteric lymph nodes both with host cells and autonomously. J Immunol. (2018 ) 202:260–7.

    Not in our library10.4049/jimmunol.1701254 (opens in a new tab)

  32. 32.

    Voedisch S Koenecke C David S Herbrand H Förster R Rhen M. Mesenteric lymph nodes confine dendritic cell-mediated dissemination of Salmonella enterica serovar typhimurium and limit systemic disease in mice. Infect Immun. (2009 ) 77:3170–80.

    Not in our library10.1128/iai.00272-09 (opens in a new tab)

  33. 33.

    John AL St. Ang WXG Huang M-N Kunder CA Chan EW Gunn MD S1P-Dependent Trafficking of Intracellular Yersinia pestis through Lymph Nodes Establishes Buboes and Systemic Infection. Immunity. (2014 ) 41:440–50.

    Not in our library10.1016/j.immuni.2014.07.013 (opens in a new tab)

  34. 34.

    Hintzen G Ohl L del Rio M-L Rodriguez-Barbosa J-I Pabst O Kocks JR. Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node. J Immunol. (2006 ) 177:7346–54.

    Not in our library10.4049/jimmunol.177.10.7346 (opens in a new tab)

  35. 35.

    Permanyer M Bošnjak B Förster R. Dendritic cells, T cells and lymphatics: dialogues in migration and beyond. Curr Opin Immunol. (2018 ) 53:173–9.

    Not in our library10.1016/j.coi.2018.05.004 (opens in a new tab)

  36. 36.

    Clatworthy MR Aronin CEP Mathews RJ Morgan NY Smith KGC Germain RN. Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes. Nat Med. (2014 ) 20:1458–63.

    Not in our library10.1038/nm.3709 (opens in a new tab)

  37. 37.

    Jang MH Sougawa N Tanaka T Hirata T Hiroi T Tohya K. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol. (2006 ) 176:803–10.

    Not in our library10.4049/jimmunol.176.2.803 (opens in a new tab)

  38. 38.

    Ivanov S Scallan JP Kim K-W Werth K Johnson MW Saunders BT. CCR7 and IRF4-dependent dendritic cells regulate lymphatic collecting vessel permeability. J Clin Invest. (2016 ) 126:1581–91.

    Not in our library10.1172/jci84518 (opens in a new tab)

  39. 39.

    Russo E Nitschké M Halin C. Dendritic cell interactions with lymphatic endothelium. Lymphat Res Biol. (2013 ) 11:172–82.

    Not in our library10.1089/lrb.2013.0008 (opens in a new tab)

  40. 40.

    Russo E Teijeira A Vaahtomeri K Willrodt A-H Bloch JS Nitschké M. Intralymphatic CCL21 promotes tissue egress of dendritic cells through afferent lymphatic vessels. Cell Rep. (2016 ) 14:1723–34.

    Not in our library10.1016/j.celrep.2016.01.048 (opens in a new tab)

  41. 41.

    Weber M Hauschild R Schwarz J Moussion C de Vries I Legler DF. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science. (2013 ) 339:328–32.

    Not in our library10.1126/science.1228456 (opens in a new tab)

  42. 42.

    Britschgi MR Favre S Luther SA. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19. Eur J Immunol. (2010 ) 40:1266–71.

    Not in our library10.1002/eji.200939921 (opens in a new tab)

  43. 43.

    Antonopoulos C Cumberbatch M Dearman RJ Daniel RJ Kimber I Groves RW. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J Immunol. (2001 ) 166:3672–7.

    Not in our library10.4049/jimmunol.166.6.3672 (opens in a new tab)

  44. 44.

    Pang IK Ichinohe T Iwasaki A. IL-1R signaling in dendritic cells replaces pattern-recognition receptors in promoting CD8+ T cell responses to influenza A virus. Nat Immunol. (2013 ) 14:246–53.

    Not in our library10.1038/ni.2514 (opens in a new tab)

  45. 45.

    Wang B Fujisawa H Zhuang L Kondo S Shivji GM Kim CS. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J Immunol. (1997 ) 159:6148–55.

    Not in our library

  46. 46.

    Scandella E Men Y Gillessen S Förster R Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood. (2002 ) 100:1354–61.

    Not in our library10.1182/blood-2001-11-0017 (opens in a new tab)

  47. 47.

    Partida-Sánchez S Goodrich S Kusser K Oppenheimer N Randall TD Lund FE. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity. (2004 ) 20:279–91.

    Not in our library10.1016/s1074-7613(04)00048-2 (opens in a new tab)

  48. 48.

    Jones EL Wee JL Demaria MC Blakeley J Ho PK Vega-Ramos J. Dendritic cell migration and antigen presentation are coordinated by the opposing functions of the tetraspanins CD82 and CD37. J Immunol. (2016 ) 196:978–87.

    Not in our library10.4049/jimmunol.1500357 (opens in a new tab)

  49. 49.

    Gartlan KH Wee JL Demaria MC Nastovska R Chang TM Jones EL. Tetraspanin CD37 contributes to the initiation of cellular immunity by promoting dendritic cell migration. Eur J Immunol. (2013 ) 43:1208–19.

    Not in our library10.1002/eji.201242730 (opens in a new tab)

  50. 50.

    Hagnerud S Manna PP Cella M Stenberg A Frazier WA Colonna M. Deficit of CD47 results in a defect of marginal zone dendritic cells, blunted immune response to particulate antigen and impairment of skin dendritic cell migration. J Immunol. (2006 ) 176:5772–8.

    Not in our library10.4049/jimmunol.176.10.5772 (opens in a new tab)

  51. 51.

    Cumberbatch M Clelland K Dearman RJ Kimber I. Impact of cutaneous IL-10 on resident epidermal Langerhans' cells and the development of polarized immune responses. J Immunol. (2005 ) 175:43–50.

    Not in our library10.4049/jimmunol.175.1.43 (opens in a new tab)

  52. 52.

    Kel JM Girard-Madoux MJH Reizis B Clausen BE. TGF-β is required to maintain the pool of immature Langerhans cells in the epidermis. J Immunol. (2010 ) 185:3248–55.

    Not in our library10.4049/jimmunol.1000981 (opens in a new tab)

  53. 53.

    Imai K Minamiya Y Koyota S Ito M Saito H Sato Y. Inhibition of dendritic cell migration by transforming growth factor-β1 increases tumor-draining lymph node metastasis. J Exp Clin Cancer Res. (2012 ) 31:3.

    Not in our library10.1186/1756-9966-31-3 (opens in a new tab)

  54. 54.

    Sawada Y Honda T Hanakawa S Nakamizo S Murata T Ueharaguchi-Tanada Y. Resolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses. J Exp Med. (2015 ) 212:1921–30.

    Not in our library10.1084/jem.20150381 (opens in a new tab)

  55. 55.

    Kabashima K Shiraishi N Sugita K Mori T Onoue A Kobayashi M. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am J Pathol. (2007 ) 171:1249–57.

    Not in our library10.2353/ajpath.2007.070225 (opens in a new tab)

  56. 56.

    Johnson LA Jackson DG. The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics. J Cell Sci. (2013 ) 126:5259–70.

    Not in our library10.1242/jcs.135343 (opens in a new tab)

  57. 57.

    Qu C Edwards EW Tacke F Angeli V Llodrá J Sanchez-Schmitz G. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J Exp Med. (2004 ) 200:1231–41.

    Not in our library10.1084/jem.20032152 (opens in a new tab)

  58. 58.

    Yabe R Shimizu K Shimizu S Azechi S Choi B-I Sudo K. CCR8 regulates contact hypersensitivity by restricting cutaneous dendritic cell migration to the draining lymph nodes. Int Immunol. (2015 ) 27:169–81.

    Not in our library10.1093/intimm/dxu098 (opens in a new tab)

  59. 59.

    Nitschke M Aebischer D Abadier M Haener S Lucic M Vigl B. Differential requirement for ROCK in dendritic cell migration within lymphatic capillaries in steady-state and inflammation. Blood. (2012 ) 120:2249–58.

    Not in our library10.1182/blood-2012-03-417923 (opens in a new tab)

  60. 60.

    Xu H Guan H Zu G Bullard D Hanson J Slater M. The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur J Immunol. (2001 ) 31:3085–93.

    Not in our library10.1002/1521-4141(2001010)31:10<3085::aid-immu3085>3.0.co;2-b (opens in a new tab)

  61. 61.

    Lämmermann T Bader BL Monkley SJ Worbs T Wedlich-Söldner R Hirsch K. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature. (2008 ) 453:51–5.

    Not in our library10.1038/nature06887 (opens in a new tab)

  62. 62.

    Cyster JG Schwab SR. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol. (2012 ) 30:69–94.

    Not in our library10.1146/annurev-immunol-020711-075011 (opens in a new tab)

  63. 63.

    Czeloth N Bernhardt G Hofmann F Genth H Förster R. Sphingosine-1-phosphate mediates migration of mature dendritic cells. J Immunol. (2005 ) 175:2960–7.

    Not in our library10.4049/jimmunol.175.5.2960 (opens in a new tab)

  64. 64.

    Idzko M Hammad H van Nimwegen M Kool M Müller T Soullié T. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J Clin Invest. (2006 ) 116:2935–44.

    Not in our library10.1172/jci28295 (opens in a new tab)

  65. 65.

    Rathinasamy A Czeloth N Pabst O Forster R Bernhardt G. The origin and maturity of dendritic cells determine the pattern of sphingosine 1-phosphate receptors expressed and required for efficient migration. J Immunol. (2010 ) 185:4072–81.

    Not in our library10.4049/jimmunol.1000568 (opens in a new tab)

  66. 66.

    Pham THM Baluk P Xu Y Grigorova I Bankovich AJ Pappu R. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J Exp Med. (2010 ) 207:17–27.

    Not in our library10.1084/jem.20091619 (opens in a new tab)

  67. 67.

    Pascale F Pascale F Contreras V Bonneau M Courbet A Chilmonczyk S. Plasmacytoid dendritic cells migrate in afferent skin lymph. J Immunol. (2008 ) 180:5963–72.

    Not in our library10.4049/jimmunol.180.9.5963 (opens in a new tab)

  68. 68.

    Yrlid U Cerovic V Milling S Jenkins CD Zhang J Crocker PR Plasmacytoid dendritic cells do not migrate in intestinal or hepatic lymph. J Immunol. (2006 ) 177:6115–21.

    Not in our library10.4049/jimmunol.177.9.6115 (opens in a new tab)

  69. 69.

    de Heer HJ Hammad H Soullié T Hijdra D Vos N Willart MAM. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med. (2004 ) 200:89–98.

    Not in our library10.1084/jem.20040035 (opens in a new tab)

  70. 70.

    Amulic B Cazalet C Hayes GL Metzler KD Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol. (2012 ) 30:459–89.

    Not in our library10.1146/annurev-immunol-020711-074942 (opens in a new tab)

  71. 71.
    Neutrophil-Derived Cytokines: Facts Beyond Expression · 2014
    No notice
  72. 72.

    Arokiasamy S Zakian C Dilliway J Wang W Nourshargh S Voisin M-B. Endogenous TNFα orchestrates the trafficking of neutrophils into and within lymphatic vessels during acute inflammation. Sci Rep. (2017 ) 7:44189.

    Not in our library10.1038/srep44189 (opens in a new tab)

  73. 73.

    Gorlino CV Ranocchia RP Harman MF García IA Crespo MI Morón G. Neutrophils exhibit differential requirements for homing molecules in their lymphatic and blood trafficking into draining lymph nodes. J Immunol. (2014 ) 193:1966–74.

    Not in our library10.4049/jimmunol.1301791 (opens in a new tab)

  74. 74.

    Rigby DA Ferguson DJP Johnson LA Jackson DG. Neutrophils rapidly transit inflamed lymphatic vessel endothelium via integrin-dependent proteolysis and lipoxin-induced junctional retraction. J Leukoc Biol. (2015 ) 98:897–912.

    Not in our library10.1189/jlb.1hi0415-149r (opens in a new tab)

  75. 75.

    Cahill RN Frost H Trnka Z. The effects of antigen on the migration of recirculating lymphocytes through single lymph nodes. J Exp Med. (1976 ) 143:870–88.

    Not in our library10.1084/jem.143.4.870 (opens in a new tab)

  76. 76.

    Neeland MR Shi W Collignon C Taubenheim N Meeusen ENT Didierlaurent AM. The lymphatic immune response induced by the adjuvant AS01: a comparison of intramuscular and subcutaneous immunization routes. J Immunol. (2016 ) 197:2704–14.

    Not in our library10.4049/jimmunol.1600817 (opens in a new tab)

  77. 77.

    Abadie V Badell E Douillard P Ensergueix D Leenen PJM Tanguy M. Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. Blood. (2005 ) 106:1843–50.

    Not in our library10.1182/blood-2005-03-1281 (opens in a new tab)

  78. 78.

    Bogoslowski A Butcher EC Kubes P. Neutrophils recruited through high endothelial venules of the lymph nodes via PNAd intercept disseminating Staphylococcus aureus. Proc Natl Acad Sci USA. (2018 ) 115:2449–54.

    Not in our library10.1073/pnas.1715756115 (opens in a new tab)

  79. 79.

    Yang C-W Strong BSI Miller MJ Unanue ER. Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants. J Immunol. (2010 ) 185:2927–34.

    Not in our library10.4049/jimmunol.1001289 (opens in a new tab)

  80. 80.

    Gresham HD Lowrance JH Caver TE Wilson BS Cheung AL Lindberg FP. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol. (2000 ) 164:3713–22.

    Not in our library10.4049/jimmunol.164.7.3713 (opens in a new tab)

  81. 81.

    Peters NC Egen JG Secundino N Debrabant A Kimblin N Kamhawi S. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science. (2008 ) 321:970–4.

    Not in our library10.1126/science.1159194 (opens in a new tab)

  82. 82.

    Chtanova T Schaeffer M Han S-J van Dooren GG Nollmann M Herzmark P. Dynamics of neutrophil migration in lymph nodes during infection. Immunity. (2008 ) 29:487–96.

    Not in our library10.1016/j.immuni.2008.07.012 (opens in a new tab)

  83. 83.

    Beauvillain C Cunin P Doni A Scotet M Jaillon S Loiry M-L. CCR7 is involved in the migration of neutrophils to lymph nodes. Blood. (2011 ) 117:1196–204.

    Not in our library10.1182/blood-2009-11-254490 (opens in a new tab)

  84. 84.

    Eash KJ Greenbaum AM Gopalan PK Link DC. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest. (2010 ) 120:2423–31.

    Not in our library10.1172/jci41649 (opens in a new tab)

  85. 85.

    Dinauer MC. Primary immune deficiencies with defects in neutrophil function. Hematology. (2016 ) 2016:43–50.

    Not in our library10.1182/asheducation-2016.1.43 (opens in a new tab)

  86. 86.

    Van de Weert–van Leeuwen PB Van Meegen MA Speirs JJ Pals DJ Rooijakkers SHM Van der Ent CK. Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator–dependent. Am J Respir Cell Mol Biol. (2013 ) 49:463–70.

    Not in our library10.1165/rcmb.2012-0502oc (opens in a new tab)

  87. 87.

    Smeekens SP van de Veerdonk FL Joosten LAB Jacobs L Jansen T Williams DL The classical CD14++ CD16− monocytes, but not the patrolling CD14+ CD16+ monocytes, promote Th17 responses to Candida albicans. Eur J Immunol. (2011 ) 41:2915–24.

    Not in our library10.1002/eji.201141418 (opens in a new tab)

  88. 88.

    Mohanty S Joshi SR Ueda I Wilson J Blevins TP Siconolfi B. Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. J Infect Dis. (2015 ) 211:1174–84.

    Not in our library10.1093/infdis/jiu573 (opens in a new tab)

  89. 89.

    Ginhoux F Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol. (2014 ) 14:392–404.

    Not in our library10.1038/nri3671 (opens in a new tab)

  90. 90.

    Calabro S Tortoli M Baudner BC Pacitto A Cortese M O'Hagan DT. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine. (2011 ) 29:1812–23.

    Not in our library10.1016/j.vaccine.2010.12.090 (opens in a new tab)

  91. 91.

    Leirião P del Fresno C Ardavín C. Monocytes as effector cells: activated Ly-6C(high) mouse monocytes migrate to the lymph nodes through the lymph and cross-present antigens to CD8+ T cells. Eur J Immunol. (2012 ) 42:2042–51.

    Not in our library10.1002/eji.201142166 (opens in a new tab)

  92. 92.

    Jakubzick C Gautier EL Gibbings SL Sojka DK Schlitzer A Johnson TE. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity. (2013 ) 39:599–610.

    Not in our library10.1016/j.immuni.2013.08.007 (opens in a new tab)

  93. 93.

    Becker HM Rullo J Chen M Ghazarian M Bak S Xiao H. α1β1 integrin-mediated adhesion inhibits macrophage exit from a peripheral inflammatory lesion. J Immunol. (2013 ) 190:4305–14.

    Not in our library10.4049/jimmunol.1202097 (opens in a new tab)

  94. 94.

    Bellingan GJ Caldwell H Howie SE Dransfield I Haslett C In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J Immunol. (1996 ) 157:2577–85.

    Not in our library

  95. 95.

    Hayes AJ Rane S Scales HE Meehan GR Benson RA Maroof A. Spatiotemporal modeling of the key migratory events during the initiation of adaptive immunity. Front Immunol. (2019 ) 10:598.

    Not in our library10.3389/fimmu.2019.00598 (opens in a new tab)

  96. 96.

    Gascoigne NRJ Rybakin V Acuto O Brzostek J. TCR signal strength and T cell development. Annu Rev Cell Dev Biol. (2016 ) 32:327–48.

    Not in our library10.1146/annurev-cellbio-111315-125324 (opens in a new tab)

  97. 97.

    Wong P Pamer EG. CD8 T cell responses to infectious pathogens. Annu Rev Immunol. (2003 ) 21:29–70.

    Not in our library10.1146/annurev.immunol.21.120601.141114 (opens in a new tab)

  98. 98.

    Zhu J Yamane H Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol. (2010 ) 28:445–89.

    Not in our library10.1146/annurev-immunol-030409-101212 (opens in a new tab)

  99. 99.

    Mackay CR Marston WL Dudler L. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med. (1990 ) 171:801–17.

    Not in our library10.1084/jem.171.3.801 (opens in a new tab)

  100. 100.

    Brown MN Fintushel SR Lee MH Jennrich S Geherin SA Hay JB. Chemoattractant receptors and lymphocyte egress from extralymphoid tissue: changing requirements during the course of inflammation. J Immunol. (2010 ) 185:4873–82.

    Not in our library10.4049/jimmunol.1000676 (opens in a new tab)

  101. 101.

    Menning A Höpken UE Siegmund K Lipp M Hamann A Huehn J. Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. Eur J Immunol. (2007 ) 37:1575–83.

    Not in our library10.1002/eji.200737201 (opens in a new tab)

  102. 102.

    Gómez D Diehl MC Crosby EJ Weinkopff T Debes GF. Effector T cell egress via afferent lymph modulates local tissue inflammation. J Immunol. (2015 ) 195:3531–6.

    Not in our library10.4049/jimmunol.1500626 (opens in a new tab)

  103. 103.

    Zhang N Schröppel B Lal G Jakubzick C Mao X Chen D. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity. (2009 ) 30:458–69.

    Not in our library10.1016/j.immuni.2008.12.022 (opens in a new tab)

  104. 104.

    Bromley SK Thomas SY Luster AD. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol. (2005 ) 6:895–901.

    Not in our library10.1038/ni1240 (opens in a new tab)

  105. 105.

    Ledgerwood LG Lal G Zhang N Garin A Esses SJ Ginhoux F. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol. (2008 ) 9:42–53.

    Not in our library10.1038/ni1534 (opens in a new tab)

  106. 106.

    Marttila-Ichihara F Turja R Miiluniemi M Karikoski M Maksimow M Niemela J. Macrophage mannose receptor on lymphatics controls cell trafficking. Blood. (2008 ) 112:64–72.

    Not in our library10.1182/blood-2007-10-118984 (opens in a new tab)

  107. 107.

    Salmi M Karikoski M Elima K Rantakari P Jalkanen S. CD44 binds to macrophage mannose receptor on lymphatic endothelium and supports lymphocyte migration via afferent lymphatics. Circ Res. (2013 ) 112:1577–82.

    Not in our library10.1161/circresaha.111.300476 (opens in a new tab)

  108. 108.

    Karikoski M Irjala H Maksimow M Miiluniemi M Granfors K Hernesniemi S. Clever-1/Stabilin-1 regulates lymphocyte migration within lymphatics and leukocyte entrance to sites of inflammation. Eur J Immunol. (2009 ) 39:3477–87.

    Not in our library10.1002/eji.200939896 (opens in a new tab)

  109. 109.

    Gray EE Ramírez-Valle F Xu Y Wu S Wu Z Karjalainen KE. Deficiency in IL-17-committed Vγ4+ γδ T cells in a spontaneous Sox13-mutant CD45.1+ congenic mouse substrain provides protection from dermatitis. Nat Immunol. (2013 ) 14:584–92.

    Not in our library10.1038/ni.2585 (opens in a new tab)

  110. 110.

    Van Rhijn I Rutten VPMG Charleston B Smits M van Eden W Koets AP Massive, sustained γδ T cell migration from the bovine skin in vivo. J Leukoc Biol. (2007 ) 81:968–73.

    Not in our library10.1189/jlb.0506331 (opens in a new tab)

  111. 111.

    Vrieling M Santema W Van Rhijn I Rutten V Koets A. γδ T cell homing to skin and migration to skin-draining lymph nodes is CCR7 independent. J Immunol. (2012 ) 188:578–84.

    Not in our library10.4049/jimmunol.1101972 (opens in a new tab)

  112. 112.

    Mackay CR Kimpton WG Brandon MR Cahill RN. Lymphocyte subsets show marked differences in their distribution between blood and the afferent and efferent lymph of peripheral lymph nodes. J Exp Med. (1988 ) 167:1755–65.

    Not in our library10.1084/jem.167.6.1755 (opens in a new tab)

  113. 113.

    Noor S Habashy AS Nance JP Clark RT Nemati K Carson MJ. CCR7-dependent immunity during acute Toxoplasma gondii infection. Infect Immun. (2010 ) 78:2257–63.

    Not in our library10.1128/iai.01314-09 (opens in a new tab)

  114. 114.

    Bardina SV Brown JA Michlmayr D Hoffman KW Sum J Pletnev AG. Chemokine receptor CCR7 restricts fatal west nile virus encephalitis. J Virol. (2017 ) 91:e02409–16

    Not in our library10.1128/jvi.02409-16 (opens in a new tab)

  115. 115.

    Olmos S Stukes S Ernst JD. Ectopic activation of Mycobacterium tuberculosis-specific CD4+ T cells in lungs of CCR7−/− mice. J Immunol. (2010 ) 184:895–901.

    Not in our library10.4049/jimmunol.0901230 (opens in a new tab)

  116. 116.

    Louveau A Herz J Alme MN Salvador AF Dong MQ Viar KE. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. (2018 ) 21:1380–91.

    Not in our library10.1038/s41593-018-0227-9 (opens in a new tab)

  117. 117.

    Dietrich T Bock F Yuen D Hos D Bachmann BO Zahn G. Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol. (2010 ) 184:535–9.

    Not in our library10.4049/jimmunol.0903180 (opens in a new tab)

  118. 118.

    Kerjaschki D Regele HM Moosberger I Nagy-Bojarski K Watschinger B Soleiman A. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol. (2004 ) 15:603–12.

    Not in our library10.1097/01.asn.0000113316.52371.2e (opens in a new tab)

  119. 119.

    Chen L Hamrah P Cursiefen C Zhang Q Pytowski B Streilein JW. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med. (2004 ) 10:813–5.

    Not in our library10.1038/nm1078 (opens in a new tab)

  120. 120.
    Obesity Impairs Lymphatic Fluid Transport and Dendritic Cell Migration to Lymph Nodes · 2013
    No notice
  121. 121.

    Damas JK Smith C Øie E Fevang B Halvorsen B Wæhre T. Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis. Arterioscler Thromb Vasc Biol. (2007 ) 27:614–20.

    Not in our library10.1161/01.atv.0000255581.38523.7c (opens in a new tab)

  122. 122.

    Luchtefeld M Grothusen C Gagalick A Jagavelu K Schuett H Tietge UJF. Chemokine receptor 7 knockout attenuates atherosclerotic plaque development. Circulation. (2010 ) 122:1621–8.

    Not in our library10.1161/circulationaha.110.956730 (opens in a new tab)

  123. 123.

    Wan W Lionakis MS Liu Q Roffê E Murphy PM. Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice. Cardiovasc Res. (2013 ) 97:580–8.

    Not in our library10.1093/cvr/cvs349 (opens in a new tab)

  124. 124.
    Statins Promote the Regression of Atherosclerosis via Activation of the CCR7-Dependent Emigration Pathway in Macrophages · 2011
    No notice
  125. 125.

    Trogan E Feig JE Dogan S Rothblat GH Angeli V Tacke F. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc Natl Acad Sci USA. (2006 ) 103:3781–6.

    Not in our library10.1073/pnas.0511043103 (opens in a new tab)

  126. 126.

    Roberts EW Broz ML Binnewies M Headley MB Nelson AE Wolf DM. Critical role for CD103+/CD141+ dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma. Cancer Cell. (2016 ) 30:324–36.

    Not in our library10.1016/j.ccell.2016.06.003 (opens in a new tab)

  127. 127.
    The role of the VEGF-C/VEGFR-3 axis in cancer progression · 2006
    No notice
  128. 128.

    Tammela T Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell. (2010 ) 140:460–76.

    Not in our library10.1016/j.cell.2010.01.045 (opens in a new tab)

  129. 129.

    Skobe M Hawighorst T Jackson DG Prevo R Janes L Velasco P. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. (2001 ) 7:192–8.

    Not in our library10.1038/84643 (opens in a new tab)

  130. 130.

    Yanai Y Furuhata T Kimura Y Yamaguchi K Yasoshima T Mitaka T. Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice. J Exp Clin Cancer Res. (2001 ) 20:419–28.

    Not in our library

  131. 131.

    Lane RS Femel J Breazeale AP Loo CP Thibault G Kaempf A. IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin. J Exp Med. (2018 ) 215:3057–74.

    Not in our library10.1084/jem.20180654 (opens in a new tab)

  132. 132.

    Lund AW Duraes FV Hirosue S Raghavan VR Nembrini C Thomas SN. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep. (2012 ) 1:191–9.

    Not in our library10.1016/j.celrep.2012.01.005 (opens in a new tab)

  133. 133.

    Habenicht LM Albershardt TC Iritani BM Ruddell A. Distinct mechanisms of B and T lymphocyte accumulation generate tumor-draining lymph node hypertrophy. Oncoimmunology. (2016 ) 5:e1204505.

    Not in our library10.1080/2162402x.2016.1204505 (opens in a new tab)

  134. 134.

    Worthington JJ Fenton TM Czajkowska BI Klementowicz JE Travis MA. Regulation of TGFβ in the immune system: an emerging role for integrins and dendritic cells. Immunobiology. (2012 ) 217:1259–65.

    Not in our library10.1016/j.imbio.2012.06.009 (opens in a new tab)

Cited by papers we hold 1

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.